Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
Paracetamol
Chefaro Ireland DAC
N02BE; N02BE01
Paracetamol
500 milligram(s)
Film-coated tablet
Product not subject to medical prescription
Anilides; paracetamol
Marketed
1992-08-20
PATIENT INFORMATION LEAFLET PARACETAMOL 500MG FILM-COATED TABLETS PARACETAMOL PLEASE READ RIGHT THROUGH THIS LEAFLET BEFORE YOU START USING THIS MEDICINE. This medicine is available without prescription, but you still need to use paracetamol tablets carefully to get the best results from them. • Keep this leaflet, you may need to read it again. • If you have any further questions, ask your pharmacist. IN THIS LEAFLET: 1. What paracetamol tablets are and what they are used for 2. Check before you take paracetamol tablets 3. How to take paracetamol tablets 4. Possible side effects 5. How to store and dispose of paracetamol tablets 6. Further information 1. WHAT PARACETAMOL TABLETS ARE AND WHAT THEY ARE USED FOR PARACETAMOL TABLETS ARE USED FOR RELIEF OF HEADACHES, INCLUDING MIGRAINE AND TENSION HEADACHES, TOOTHACHE, BACKACHE, RHEUMATIC AND MUSCLE PAINS, NEURALGIA AND PERIOD PAIN. It also relieves sore throat and the feverishness, aches and pains of colds and flu. The active ingredient is paracetamol which is a painkiller and also reduces your temperature when you have a fever. 2. CHECK BEFORE YOU TAKE PARACETAMOL TABLETS ☒ DO NOT TAKE PARACETAMOL TABLETS: • IF YOU HAVE EVER HAD AN ALLERGIC REACTION to paracetamol or to any of the other ingredients (listed in Section 6). • if you are TAKING OTHER MEDICINES CONTAINING PARACETAMOL. • if you are UNDER 6 YEARS unless your doctor tells you to. ! ASK YOUR DOCTOR BEFORE YOU TAKE THIS MEDICINE: • if you have SEVERE LIVER or KIDNEY DISEASE, including ALCOHOLIC LIVER DISEASE. ! OTHER MEDICINES AND PARACETAMOL 500MG TABLETS Talk to your doctor or pharmacist before taking these tablets if you are taking any prescribed medicines; particularly METOCLOPRAMIDE or DOMPERIDONE (for NAUSEA [feeling sick] or VOMITING [being sick]); COLESTYRAMINE (to lower BLOOD CHOLESTEROL); PROBENECID (gout), flucloxacillin (antibiotic), due to a serious risk of blood and fluid abnormality (high anion gap metabolic acidosis) that must have urgent treatment and which may occur particularl Lesen Sie das vollständige Dokument
Health Products Regulatory Authority 09 June 2022 CRN00CYCJ Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 500 mg Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains paracetamol 500 mg. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White film coated capsule-shaped tablet with flat edges and a break line on one side. The break line is only to facilitate breaking for ease of swallowing and do not divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Paracetamol tablets are a mild analgesic and antipyretic. The tablets are recommended for use in the short term management of headaches, including migraine and tension headaches, backache, rheumatic and muscle pain, period pains, nerve pains, toothache and for relieving of fever, aches and pains of colds and flu. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral administration only. AGE HOW MUCH HOW OFTEN Adults and children over 16years 1 or 2 tablets Every 4-6 hours, as required. Don't take more than 8 tablets (4 doses) in any 24 hours. Children 12-15 years 1 to 1½ tablets Every 4-6 hours, as required. Don't take more than 6 tablets (4 doses) in any 24 hours. Children 10-12 years 1 tablet Every 4-6 hours, as required. Don't take more than 4 tablets (4 doses) in any 24 hours. Children 6-10 years ½ tablet Every 4-6 hours, as required. Don't take more than 2 tablets (4 doses) in any 24 hours. Paracetamol tablets are not suitable for children under 10 years of age. These doses should not be repeated more frequently than every 4 hours and not more than 4 doses should be given in any 24 hour period. Maximum duration of continued use without medical advice: 3 days. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Use in children under 10 years of age. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Hepatic impairment Health Products Regulatory Authority 09 June 2022 CRN00CYCJ Lesen Sie das vollständige Dokument